Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients
NCT07391046
Asplenia, Autoimmune Diseases
View Trial DetailsNCT Number: NCT00551837
The purpose of this study is to evaluate the immune response to a routine influenza vaccination. Influenza vaccination is given as part of routine standard of care in these individuals and is not part of the study protocol. The study will evaluate for a change in response to common antigens over time after influenza vaccination to determine if changes are related to the development of chronic rejection after solid-organ transplantation. We hypothesize that the influenza vaccine contributes to the alloreactivity of T cells verses common HLA types in the donor pool.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Cleveland Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07391046
Asplenia, Autoimmune Diseases
View Trial DetailsNCT04328688
Bacterial Infections and Mycoses, Infections
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01178177
Aspergillosis, Bacterial Infections and Mycoses
View Trial DetailsNCT01826721
Behavior, Health Behavior
Toronto, Ontario, Canada
View Trial Details